HCA Healthcare Q2 net income rises 2.8%; 2026 profit guidance lowered
HCA Healthcare reported second-quarter 2026 revenue of $20.230 billion, up 8.7%, and diluted EPS of $7.62, up 11.6%. The company lowered its 2026 guidance for net income, EPS and Adjusted EBITDA, citing a payer mix shift from uninsured volume tied to health insurance exchanges, which it estimated reduced second-quarter income before income taxes by approximately $400 million.
Key points
- Q2 2026 revenue was $20.230 billion, up 8.7% from $18.605 billion; diluted EPS was $7.62 versus $6.83 a year earlier.
- Revised 2026 diluted EPS guidance is $28.70 to $30.50, down from $29.10 to $31.50; net income guidance is $6.300 to $6.700 billion, down from $6.495 to $7.035 billion.
- The exchange-related payer mix shift had an unfavorable impact of approximately $400 million on Q2 income before income taxes, partly offset by about $400 million of incremental Medicaid Supplemental Payment Program benefit.
- The Board declared a quarterly cash dividend of $0.78 per share, payable September 30, 2026 to holders of record on September 16, 2026.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:21 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 24, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.